Searched for
BIOCON STOCK UPDATE
Biocon shares rally nearly 6% after unit receives USFDA nod for cancer drugBiocon's shares surged following USFDA approval for Jobevne, a biosimilar to Avastin, used in treating various cancers. This marks Biocon's...- Stocks to buy today: Morgan Stanley upgrades AB Capital; Motilal Oswal sees 20% upside in D-Mart post Q3 resultsMotilal Oswal Financial Services (MOSL) has reaffirmed its confidence in Avenue Supermarts, highlighting its leadership transition and long...
- Biocon shares surge over 4% after Malaysia unit gets clearance from the USFDABiocon shares increased by 4.5% after the US FDA classified its Malaysian insulin facilities as Voluntary Action Indicated. This followed a...
- Stock Radar: Biocon stock price breaks out from upper band of a Symmetrical Triangle; should you buy?Biocon Ltd has broken out of the Symmetrical Triangle formation on daily charts, suggesting a potential rise in stock price. Experts advise...
- Biocon shares zoom 4% as Jefferies upgrades to "hold" amid positive news inflow, sets Rs 400 targetBiocon share price: This upgrade reflects a more positive outlook on the company following recent favorable news flow, particularly concern...
- Stocks to buy today: CLSA upgrades ONGC; Citi initiates buy on Hyundai Motor IndiaCLSA has upgraded ONGC to "High Conviction Overweight-PF," citing multiple production and realization triggers, alongside attractive valuat...
- Biocon shares surge 5% after USFDA classifies Bengaluru site as VAIBiocon Share Price: Biocon shares surged 5.4% after FDA classified its Bengaluru facility as Voluntary Action Indicated (VAI). The stock is...
- Here's why CA Rudramurthy BV is bullish on IRCTCDefinitely, yesterday there were very-very clear signs of pharma just shooting up and that is a clear indication that yes, most of the stoc...
- Smallcaps usher in 2024 with a bang as over 100 stocks see double-digit weekly gainsAbout 12 smallcap stocks have gained over 25%, with Alok Industries being the topper with a 52% surge. It was followed by Sun Pharma Advanc...
- PNB Housing, KPIT Technologies among 10 stocks with RSI trending upOn September 28, Thursday, StockEdge reported that 18 stocks were trending up, signaling a potential bullish wave. ETMarkets spotlights 10 ...
- Biocon, SAIL among 10 stocks with RSI trending downOn September 22, Friday, StockEdge identified 40 stocks with a declining Relative Strength Index (RSI). ETMarkets has chosen 10 of these st...
- Biocon Q4 Results: Cons PAT grows 31% YoY to Rs 313 crore, revenue surges 57%The board has recommended a final dividend payout of Rs 1.50 per share. In FY23, Biocon’s revenue grew almost 37% to Rs 11,174 crore, while...
- MSCI index rejig today: These 4 stocks likely in limelight ahead of rebalancingThe recent massive sell-off in Adani Group companies in the backdrop of the allegations made by US-based short seller Hindenburg Research, ...
- Biocon plunges 5% even as Q1 profit rises 71%Siddharth Mittal, CEO & Managing Director, Biocon, said, “The strong year-on-year growth of the segment was driven by both our API and Form...
- Market movers: LIC shareholders lose Rs 77K crore in four days; Paytm gets 4% lift ahead of Q4 showLIC stock has fallen 13 per cent from its issue price of Rs 949 to Rs 826. In that process, shareholders of the company have lost over Rs 7...
- Stock market update: Pharma stocks down; Biocon sheds 3%The Nifty Pharma index was trading 0.05 per cent down at 12026.75.
- Stock market update: Pharma stocks mixed; Biocon falls 1%The Nifty Pharma index was trading 0.01 per cent down at 11536.4.
- Biocon-Mylan's cancer drug gets USFDA nodFulphila is expected to contribute to Biocon’s revenue in FY19, as well as to its profits through a profitshare arrangement with Mylan.
- Biocon rallies over 7% as USFDA issues CRL for proposed biosimilarThis product is a part of the biosimilars portfolio being developed jointly by Biocon and Mylan, the company said in a BSE filing.
- Is it time to book profits on Biocon counter post Syngene listing?Biocon has gained nearly 9 per cent in the past six months, compared to a 2 per cent fall in the BSE benchmark Sensex.
Load More
